Zhao L - Search Results

1

SOX17 Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary Hypertension.

Walters R, Vasilaki E, Aman J, Chen CN, Wu Y, Liang OD, Ashek A, Dubois O, Zhao L, Sabrin F, Cebola I, Ferrer J, Morrell NW, Klinger JR, Wilkins MR, Zhao L, Rhodes CJ. Walters R, et al. Among authors: zhao l. Circulation. 2023 May 23;147(21):1606-1621. doi: 10.1161/CIRCULATIONAHA.122.061940. Epub 2023 Apr 17. Circulation. 2023. PMID: 37066790 Free PMC article.

2

Adrenomedullin activity in chronically hypoxic rat lungs.

Zhao L, Brown LA, Owji AA, Nunez DJ, Smith DM, Ghatei MA, Bloom SR, Wilkins MR. Zhao L, et al. Am J Physiol. 1996 Aug;271(2 Pt 2):H622-9. doi: 10.1152/ajpheart.1996.271.2.H622. Am J Physiol. 1996. PMID: 8770104

3

The regulation of pulmonary vascular tone.

Wilkins MR, Zhao L, al-Tubuly R. Wilkins MR, et al. Among authors: zhao l. Br J Clin Pharmacol. 1996 Jul;42(1):127-31. doi: 10.1046/j.1365-2125.1996.37117.x. Br J Clin Pharmacol. 1996. PMID: 8807153 Free PMC article. Review.

4

NPR-A-Deficient mice show increased susceptibility to hypoxia-induced pulmonary hypertension.

Zhao L, Long L, Morrell NW, Wilkins MR. Zhao L, et al. Circulation. 1999 Feb 9;99(5):605-7. doi: 10.1161/01.cir.99.5.605. Circulation. 1999. PMID: 9950655

5

Genetic determination of cardiac mass in normotensive rats: results from an F344xWKY cross.

Sebkhi A, Zhao L, Lu L, Haley CS, Nunez DJ, Wilkins MR. Sebkhi A, et al. Among authors: zhao l. Hypertension. 1999 Apr;33(4):949-53. doi: 10.1161/01.hyp.33.4.949. Hypertension. 1999. PMID: 10205229

6

Right ventricular hypertrophy secondary to pulmonary hypertension is linked to rat chromosome 17: evaluation of cardiac ryanodine Ryr2 receptor as a candidate.

Zhao L, Sebkhi A, Nunez DJ, Long L, Haley CS, Szpirer J, Szpirer C, Williams AJ, Wilkins MR. Zhao L, et al. Circulation. 2001 Jan 23;103(3):442-7. doi: 10.1161/01.cir.103.3.442. Circulation. 2001. PMID: 11157698

7

Sildenafil inhibits hypoxia-induced pulmonary hypertension.

Zhao L, Mason NA, Morrell NW, Kojonazarov B, Sadykov A, Maripov A, Mirrakhimov MM, Aldashev A, Wilkins MR. Zhao L, et al. Circulation. 2001 Jul 24;104(4):424-8. doi: 10.1161/hc2901.093117. Circulation. 2001. PMID: 11468204 Clinical Trial.

8

Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic Peptide activity.

Zhao L, Mason NA, Strange JW, Walker H, Wilkins MR. Zhao L, et al. Circulation. 2003 Jan 21;107(2):234-7. doi: 10.1161/01.cir.0000050653.10758.6b. Circulation. 2003. PMID: 12538421

9

Pivotal role for endothelial tetrahydrobiopterin in pulmonary hypertension.

Khoo JP, Zhao L, Alp NJ, Bendall JK, Nicoli T, Rockett K, Wilkins MR, Channon KM. Khoo JP, et al. Among authors: zhao l. Circulation. 2005 Apr 26;111(16):2126-33. doi: 10.1161/01.CIR.0000162470.26840.89. Epub 2005 Apr 11. Circulation. 2005. PMID: 15824200

10

Synergy between natriuretic peptides and phosphodiesterase 5 inhibitors ameliorates pulmonary arterial hypertension.

Baliga RS, Zhao L, Madhani M, Lopez-Torondel B, Visintin C, Selwood D, Wilkins MR, MacAllister RJ, Hobbs AJ. Baliga RS, et al. Among authors: zhao l. Am J Respir Crit Care Med. 2008 Oct 15;178(8):861-9. doi: 10.1164/rccm.200801-121OC. Epub 2008 Aug 8. Am J Respir Crit Care Med. 2008. PMID: 18689467 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35,044 results

Search Page